SUN PHARMACEUTICAL INDUSTRIES
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹48,497 Cr | ₹43,886 Cr | ₹67,191 Cr | ₹61,462 Cr | ₹59,424 Cr |
Sales | ₹47,130 Cr | ₹42,785 Cr | ₹66,963 Cr | ₹61,197 Cr | ₹58,912 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹628 Cr | ₹494 Cr | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹738 Cr | ₹607 Cr | ₹228 Cr | ₹265 Cr | ₹512 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹48,497 Cr | ₹43,886 Cr | ₹38,654 Cr | ₹33,498 Cr | ₹32,838 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹292 Cr | ₹-687 Cr | ₹-108 Cr | ₹-638 Cr | ₹301 Cr |
Raw Material Consumed | ₹10,370 Cr | ₹11,349 Cr | ₹10,459 Cr | ₹9,328 Cr | ₹8,930 Cr |
Opening Raw Materials | ₹3,478 Cr | ₹2,914 Cr | ₹3,344 Cr | ₹2,894 Cr | ₹2,784 Cr |
Purchases Raw Materials | ₹6,555 Cr | ₹8,342 Cr | ₹6,618 Cr | ₹6,604 Cr | ₹5,625 Cr |
Closing Raw Materials | ₹3,130 Cr | ₹3,478 Cr | ₹2,914 Cr | ₹3,344 Cr | ₹2,894 Cr |
Other Direct Purchases / Brought in cost | ₹3,466 Cr | ₹3,572 Cr | ₹3,410 Cr | ₹3,175 Cr | ₹3,414 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹761 Cr | ₹830 Cr | ₹703 Cr | ₹596 Cr | ₹586 Cr |
Electricity & Power | ₹761 Cr | ₹830 Cr | ₹703 Cr | ₹596 Cr | ₹586 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹9,429 Cr | ₹8,296 Cr | ₹7,301 Cr | ₹6,126 Cr | ₹5,704 Cr |
Salaries, Wages & Bonus | ₹8,331 Cr | ₹7,340 Cr | ₹6,444 Cr | ₹5,399 Cr | ₹5,045 Cr |
Contributions to EPF & Pension Funds | ₹529 Cr | ₹514 Cr | ₹469 Cr | ₹374 Cr | ₹361 Cr |
Workmen and Staff Welfare Expenses | ₹497 Cr | ₹378 Cr | ₹336 Cr | ₹304 Cr | ₹261 Cr |
Other Employees Cost | ₹72 Cr | ₹63 Cr | ₹52 Cr | ₹48 Cr | ₹37 Cr |
Other Manufacturing Expenses | ₹2,187 Cr | ₹1,937 Cr | ₹1,881 Cr | ₹3,487 Cr | ₹3,342 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹630 Cr | ₹561 Cr | ₹558 Cr | ₹542 Cr | ₹618 Cr |
Repairs and Maintenance | ₹780 Cr | ₹657 Cr | ₹525 Cr | ₹473 Cr | ₹403 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹777 Cr | ₹719 Cr | ₹798 Cr | ₹2,472 Cr | ₹2,321 Cr |
General and Administration Expenses | ₹5,253 Cr | ₹4,256 Cr | ₹3,271 Cr | ₹2,225 Cr | ₹2,431 Cr |
Rent , Rates & Taxes | ₹827 Cr | ₹729 Cr | ₹649 Cr | ₹417 Cr | ₹385 Cr |
Insurance | ₹304 Cr | ₹299 Cr | ₹262 Cr | ₹230 Cr | ₹192 Cr |
Printing and stationery | ₹171 Cr | ₹67 Cr | ₹61 Cr | ₹51 Cr | ₹46 Cr |
Professional and legal fees | ₹2,953 Cr | ₹2,312 Cr | ₹1,803 Cr | ₹1,168 Cr | ₹1,147 Cr |
Traveling and conveyance | ₹818 Cr | ₹642 Cr | ₹374 Cr | ₹237 Cr | ₹543 Cr |
Other Administration | ₹180 Cr | ₹207 Cr | ₹122 Cr | ₹122 Cr | ₹119 Cr |
Selling and Distribution Expenses | ₹5,780 Cr | ₹5,226 Cr | ₹4,096 Cr | ₹3,104 Cr | ₹3,654 Cr |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | ₹223 Cr | ₹207 Cr | ₹195 Cr | ₹203 Cr | ₹213 Cr |
Freight and Forwarding | ₹812 Cr | ₹934 Cr | ₹793 Cr | ₹622 Cr | ₹572 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹4,744 Cr | ₹4,085 Cr | ₹3,108 Cr | ₹2,278 Cr | ₹2,870 Cr |
Miscellaneous Expenses | ₹1,676 Cr | ₹1,091 Cr | ₹1,170 Cr | ₹803 Cr | ₹916 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | ₹91 Cr | ₹43 Cr | ₹18 Cr | ₹4.31 Cr | ₹107 Cr |
Losson disposal of fixed assets(net) | ₹31 Cr | ₹3.65 Cr | ₹14 Cr | ₹2.24 Cr | ₹8.69 Cr |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹1,554 Cr | ₹1,044 Cr | ₹1,139 Cr | ₹797 Cr | ₹800 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹35,748 Cr | ₹32,298 Cr | ₹28,773 Cr | ₹25,030 Cr | ₹25,863 Cr |
Operating Profit (Excl OI) | ₹12,749 Cr | ₹11,588 Cr | ₹9,882 Cr | ₹8,468 Cr | ₹6,974 Cr |
Other Income | ₹1,628 Cr | ₹694 Cr | ₹1,437 Cr | ₹859 Cr | ₹652 Cr |
Interest Received | ₹1,023 Cr | ₹385 Cr | ₹553 Cr | ₹211 Cr | ₹355 Cr |
Dividend Received | ₹103 Cr | ₹146 Cr | ₹215 Cr | ₹256 Cr | ₹56 Cr |
Profit on sale of Fixed Assets | ₹21 Cr | ₹11 Cr | ₹49 Cr | ₹16 Cr | ₹3.47 Cr |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | ₹29 Cr | ₹15 Cr | ₹5.98 Cr | ₹12 Cr | ₹5.22 Cr |
Foreign Exchange Gains | ₹36 Cr | ₹-126 Cr | ₹154 Cr | ₹24 Cr | ₹16 Cr |
Others | ₹416 Cr | ₹263 Cr | ₹460 Cr | ₹340 Cr | ₹216 Cr |
Operating Profit | ₹14,377 Cr | ₹12,281 Cr | ₹11,319 Cr | ₹9,327 Cr | ₹7,626 Cr |
Interest | ₹238 Cr | ₹172 Cr | ₹127 Cr | ₹141 Cr | ₹303 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | - | - | - | - | - |
Other Interest | ₹238 Cr | ₹172 Cr | ₹127 Cr | ₹141 Cr | ₹303 Cr |
PBDT | ₹14,139 Cr | ₹12,109 Cr | ₹11,192 Cr | ₹9,185 Cr | ₹7,323 Cr |
Depreciation | ₹2,557 Cr | ₹2,529 Cr | ₹2,144 Cr | ₹2,080 Cr | ₹2,053 Cr |
Profit Before Taxation & Exceptional Items | ₹11,582 Cr | ₹9,580 Cr | ₹9,048 Cr | ₹7,106 Cr | ₹5,270 Cr |
Exceptional Income / Expenses | ₹-494 Cr | ₹-171 Cr | ₹-4,567 Cr | ₹-4,306 Cr | ₹-261 Cr |
Profit Before Tax | ₹11,088 Cr | ₹9,408 Cr | ₹4,481 Cr | ₹2,799 Cr | ₹5,010 Cr |
Provision for Tax | ₹1,439 Cr | ₹848 Cr | ₹1,076 Cr | ₹515 Cr | ₹823 Cr |
Current Income Tax | ₹1,989 Cr | ₹1,869 Cr | ₹354 Cr | ₹957 Cr | ₹1,320 Cr |
Deferred Tax | ₹-550 Cr | ₹-1,022 Cr | ₹721 Cr | ₹-443 Cr | ₹-497 Cr |
Other taxes | - | - | - | - | - |
Profit After Tax | ₹9,648 Cr | ₹8,561 Cr | ₹3,406 Cr | ₹2,285 Cr | ₹4,187 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹-34 Cr | ₹-39 Cr | ₹-117 Cr | ₹631 Cr | ₹-407 Cr |
Share of Associate | ₹-38 Cr | ₹-48 Cr | ₹-17 Cr | ₹-12 Cr | ₹-15 Cr |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹9,576 Cr | ₹8,474 Cr | ₹3,273 Cr | ₹2,904 Cr | ₹3,765 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹43,610 Cr | ₹37,646 Cr | ₹36,598 Cr | ₹35,320 Cr | ₹33,330 Cr |
Appropriations | ₹53,187 Cr | ₹46,119 Cr | ₹39,871 Cr | ₹38,224 Cr | ₹37,095 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | ₹57 Cr |
Other Appropriation | ₹1,094 Cr | ₹709 Cr | ₹546 Cr | ₹307 Cr | ₹998 Cr |
Equity Dividend % | ₹1,350.00 | ₹1,150.00 | ₹1,000.00 | ₹750.00 | ₹400.00 |
Earnings Per Share | ₹39.91 | ₹35.32 | ₹13.64 | ₹12.10 | ₹15.69 |
Adjusted EPS | ₹39.91 | ₹35.32 | ₹13.64 | ₹12.10 | ₹15.69 |
Compare Income Statement of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹457,018.7 Cr | -2% | 4.3% | 65.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹143,952.0 Cr | -0.5% | 6.4% | 44.2% | Stock Analytics | |
CIPLA | ₹131,056.0 Cr | -2.9% | -1.8% | 39.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,731.0 Cr | -1.8% | -2.2% | 20.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,745.0 Cr | -1.6% | -6.3% | 73.8% | Stock Analytics | |
MANKIND PHARMA | ₹102,507.0 Cr | 0.7% | 8.1% | 41.1% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -2% |
4.3% |
65.1% |
SENSEX | -5.3% |
-1.6% |
23.1% |
You may also like the below Video Courses